Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Archemix and Nuvelo expand aptamer collaboration

Aug. 7, 2006

Nostrum obtains rights to clot busting therapeutic protein from IMTECH

Aug. 7, 2006

ATryn approved for use in E.U.

Aug. 3, 2006

Bristol-Myers Squibb patents novel coagulation Factor VIIa inhibitors

Aug. 2, 2006

New agents reported for thrombotic disorders and associated complications

July 27, 2006

Termination of TROICA study of Metalyse in out-of-hospital cardiac arrest

July 27, 2006

TGN-255 shows potential as an anticoagulant in hemodialysis patients

July 18, 2006

Preclinical thrombolytic activity of HTU-PA shown in rat, hamster, rabbit and dog models

July 13, 2006

Portola studies oral Factor Xa inhibitor in knee replacement surgery patients

July 13, 2006

New coagulation factor Xa inhibitors prepared and tested

July 11, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...